Xu, Wei https://orcid.org/0009-0008-3338-4545
Mesa-Eguiagaray, Ines
Morris, David M.
Wang, Chengjia
Gray, Calum D. https://orcid.org/0000-0002-2816-4707
Sjöström, Samuel
Papanastasiou, Giorgos https://orcid.org/0000-0002-1939-296X
Badr, Sammy https://orcid.org/0000-0002-3485-6531
Paccou, Julien
Li, Xue https://orcid.org/0000-0001-6880-2577
Timmers, Paul R. H. J.
Timofeeva, Maria https://orcid.org/0000-0002-2503-4253
Farrington, Susan M. https://orcid.org/0000-0001-5955-7389
Dunlop, Malcolm G. https://orcid.org/0000-0002-3033-5851
Semple, Scott I.
MacGillivray, Tom https://orcid.org/0000-0001-5120-0086
Theodoratou, Evropi https://orcid.org/0000-0001-5887-9132
Cawthorn, William P. https://orcid.org/0000-0001-7832-5057
Funding for this research was provided by:
RCUK | Medical Research Council (MR/S010505/1)
British Heart Foundation (RE/18/5/34216, FS/4yPhD/F/22/34175C, RE/18/5/34216, RG/16/10/32375)
Cancer Research UK (C31250/A22804)
Article History
Received: 5 June 2024
Accepted: 10 December 2024
First Online: 2 January 2025
Change Date: 9 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-025-59574-9
Competing interests
: G.P. is currently an employee of Pfizer; however, Pfizer had no role in the design or interpretation of this research. All other authors declare no competing interests.